Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice
- PMID: 23594179
- DOI: 10.1111/hiv.12036
Limitations to the identification of HIV-associated neurocognitive disorders in clinical practice
Abstract
Objectives: The objective of this study was to establish the level of awareness of HAND among healthcare providers, the screening tools that are currently used in its detection and factors that limit cognitive assessments.
Methods: We distributed a 12-item questionnaire to doctors and nurses who work in the Department of Genitourinary Medicine and Infectious Disease (GUIDE) service and also to doctors who work in the emergency department (ED) at St James Hospital.
Results: 35 surveys were collected, 54% (n = 19) from the GUIDE service and 46% (n = 16) from the ED. 82% (n = 29) of participants were doctors from interns to consultants. There was reasonable appreciation among participants with regards the prevalence of neurocognitive impairment (estimated at 29.1% among patients on HAART, and 39.3% among patients not on HAART). Screening tools were rarely used by GUIDE and ED clinicians (25% vs. 15% of the time). The Mini Mental State Examination (MMSE) was previously used by 37% (n = 13) of the group. Very few people had used the HIV Dementia Scale (HIVDS) 6% (n = 2). 34% of respondents felt that 'Orientation in Person, Place and Time was a sufficient screening tool for cognitive assessment'. Lack of time, exposed environment and lack of availability of screening tool were cited as limitations to cognitive screening in the ED environment.
Conclusions: This study examines awareness of HAND among healthcare providers and also reasons for inadequate assessment. There is a need for consensus on screening guidelines. A quick, easy to use and readily available screening tool may have a role in the acute setting in identifying high-risk patients.
Keywords: HIV; neurocognitive impairment; survey study.
© 2013 British HIV Association.
Comment in
-
Routine screening for cognitive and psychological impairment in HIV-infected patients.HIV Med. 2014 May;15(5):317-8. doi: 10.1111/hiv.12130. HIV Med. 2014. PMID: 24690116 No abstract available.
Similar articles
-
Knowledge, skills and attitudes of doctors towards assessing cognition in older patients in the emergency department.Postgrad Med J. 2013 Mar;89(1049):137-41. doi: 10.1136/postgradmedj-2012-131226. Epub 2012 Oct 30. Postgrad Med J. 2013. PMID: 23112215
-
Rapid human immunodeficiency virus testing in the pediatric emergency department: a national survey of attitudes among pediatric emergency practitioners.Pediatr Emerg Care. 2012 Dec;28(12):1257-62. doi: 10.1097/PEC.0b013e3182767add. Pediatr Emerg Care. 2012. PMID: 23187980
-
Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?J Infect Chemother. 2014 Mar;20(3):217-9. doi: 10.1016/j.jiac.2013.10.005. Epub 2014 Jan 18. J Infect Chemother. 2014. PMID: 24462448
-
Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities.AIDS Care. 2014 Feb;26(2):160-8. doi: 10.1080/09540121.2013.819401. Epub 2013 Jul 22. AIDS Care. 2014. PMID: 23869661 Review.
-
Perioperative Neurocognitive Screening Tools for At-Risk Surgical Patients.Neurol Clin Pract. 2022 Feb;12(1):76-84. doi: 10.1212/CPJ.0000000000001132. Neurol Clin Pract. 2022. PMID: 36157624 Free PMC article. Review.
Cited by
-
Quality of life in people living with HIV-associated neurocognitive disorder: A scoping review study.PLoS One. 2021 May 19;16(5):e0251944. doi: 10.1371/journal.pone.0251944. eCollection 2021. PLoS One. 2021. PMID: 34010362 Free PMC article.
-
Healthcare Workers' Perspectives on the Utilization of the International HIV Dementia Scale for the Screening HIV-Associated Neurocognitive Disorders: A Qualitative Study at TASO Centres in Central and Southwestern Uganda.HIV AIDS (Auckl). 2024 May 28;16:229-243. doi: 10.2147/HIV.S444668. eCollection 2024. HIV AIDS (Auckl). 2024. PMID: 38827783 Free PMC article.
-
Adjunctive and long-acting nanoformulated antiretroviral therapies for HIV-associated neurocognitive disorders.Curr Opin HIV AIDS. 2014 Nov;9(6):585-90. doi: 10.1097/COH.0000000000000111. Curr Opin HIV AIDS. 2014. PMID: 25226025 Free PMC article. Review.
-
Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.Curr Top Behav Neurosci. 2021;50:429-478. doi: 10.1007/7854_2019_117. Curr Top Behav Neurosci. 2021. PMID: 32677005 Review.
-
Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits.Neurology. 2014 Jun 17;82(24):2213-22. doi: 10.1212/WNL.0000000000000526. Epub 2014 May 21. Neurology. 2014. PMID: 24850492 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources